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INTRODUCTION
Erythropoietin (Epo) is a principal regulator of erythro-
poiesis, which supports the survival of erythroid progenitor
cells and stimulates their proliferation and differentiation via
binding to its cognate cell surface receptor (EpoR) [1,2]. EpoR
is a member of the cytokine receptor superfamily and lacks an
intrinsic tyrosine kinase domain. Binding of Epo to the EpoR
elicits rapid tyrosine phosphorylation events in a series of
intracellular signaling molecules. This includes activation of
an EpoR-associated tyrosine kinase, Janus kinase 2, and signal
transduction and activation transcriptional factor 5 [3-12].
The murine (m) and human (h) EpoR genes have been iso-
lated and cloned [13-19]. EpoR has been reported to be pri-
marily expressed on erythroid progenitors, megakaryocytes,
placental cells, fetal liver cells, endothelial cells, and neural
cells [20-27]. In erythroid lineages, expression of EpoR is very
low or absent on immature progenitor cells, such as the
burst-forming unit–erythroid (BFU-E), but increases with the
maturation of these cells into colony-forming unit–erythroid
(CFU-E) and then decreases rapidly with differentiation into
mature red blood cells [24,25]. Epo provides both prolifera-
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ABSTRACT
To evaluate the role of the erythropoietin (Epo) receptor (R) in erythropoiesis in more primitive stem cells, we
assessed the influence of retrovirus-mediated gene transfer of human (h) EpoR complementary DNA (cDNA) into
murine embryonic stem (ES) cells on erythroid differentiation of these cells. The hEpoR cDNA was efficiently
transduced into ES cells, forming hEpoR that stably expressed ES (ES-hEpoR) cells. Expression of hEpoR cDNA was
confirmed in ES-hEpoR cells by reverse transcriptase–polymerase chain reaction and Northern blot analysis. Colony
assays demonstrated that definitive erythroid and primitive erythroid colonies were significantly increased from ES-
hEpoR cells, when compared with mock virus–transduced ES (ES-Neo) cells, during the time course of differentia-
tion induced by withdrawal of leukemia inhibitory factor, in either the presence or the absence of Epo. Multipoten-
tial colony-forming units (CFU-Mix) were also increased in ES-hEpoR cells at different stages of differentiation, but
no changes were detected for CFU–granulocyte-macrophage colonies (CFU-GM). Time course studies by North-
ern blot analysis demonstrated elevated levels of expression of β-H1 and β-Major globin genes in embryoid bodies
derived from ES-hEpoR cells stimulated with Epo, when compared with similar expression from ES-Neo cells.
Expression of the GATA-1 gene was enhanced in ES-hEpoR cells, when compared with ES-Neo cells, beginning
immediately after initiation of the cultures until 8 days of differentiation. These data indicate that primitive and
definitive erythropoiesis in differentiating embryoid bodies can be enhanced by retrovirus-mediated gene transfer
of an hEpoR gene. 
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tion signals to BFU-E and differentiation signals to CFU-E
[1,2]. Overexpression of EpoR in immature hematopoietic
cells enhances BFU-E numbers in response to Epo [27,28].
The Epo–EpoR signaling pathway plays an important
role in early embryonic erythropoiesis as well. EpoR messen-
ger RNA (mRNA) accumulation begins in murine mesoderm
cell masses of the developing yolk sac of the neural plate-
stage embryo (E7.5) before the development of morphologi-
cally recognized erythroblasts, and high levels of EpoR
mRNA are expressed in yolk sac blood islands at the early
somite stage (E8.5) [29]. Epo–EpoR signaling is functionally
active during the initial proliferation and differentiation of
primary yolk sac erythroblasts [29]. Targeted gene disruption
of either the Epo or the EpoR gene leads to significant
decreases in the number of mesoderm yolk sac erythroblasts
circulating in the blood stream of E11-12 mutant murine
embryos, failure of deﬁnitive fetal liver erythropoiesis, severe
anemia, and fetal death. However, almost normal numbers of
primitive erythroblasts were found in 2 9.5 EpoR–null
embryos, suggesting that in vivo, EpoR contributes to deﬁni-
tive erythropoiesis in yolk sac in mesoderm [30,31].
However, whether Epo–EpoR induces an instructive sig-
nal for erythroid differentiation in hematopoietic stem cells
or simply serves as a survival factor for committed erythroid
progenitor cells remains uncertain. Injection of a recombi-
nant retrovirus carrying a constitutively active EpoR, or nor-
mal EpoR, induces erythropoiesis in infected mice, suggesting
that EpoR induces recruitment of immature erythroid precur-
sors [27,32]. EpoR expressed in interleukin (IL)-3–dependent
Ba/F3 lymphocytes transmits both proliferation and differen-
tiation signals, and accumulation of globin gene mRNA was
found in the transduced cells after induction with Epo, sug-
gesting that EpoR plays a role in determining a cell’s lineage
[33-35]. On the other hand, chimeric receptors constructed
by replacing the cytoplasmic tail of constitutively active EpoR
with diverse cytokine receptors (eg, c-mpl and granulocyte-
colony stimulating factor [G-CSF] receptor) support the ﬁnal
erythroid development in vitro and in vivo [36]. Prolactin
receptor fully supports differentiation of EpoR–/– erythroid
progenitor cells [37]. EpoR is also not required for embryonal
primitive erythropoiesis [31]. Pluripotential hematopoietic
progenitor cells expressing EpoR do not differentiate prefer-
entially toward erythropoiesis in transgenic mice [38]. These
results suggest that EpoR-speciﬁc signals are not required for
erythroid differentiation. 
Previous studies have shown that the proﬁle of hemato-
poietic progenitor cells from cord blood can be enhanced
toward CFU–granulocyte, erythroid, monocyte, mega-
karyocyte (CFU-GEMM) and BFU-E by retrovirus-medi-
ated gene transfer at the single-cell level [28] and at the sin-
gle daughter cell level [39]. Based on these studies, we
believed that the effect of exogenously expressed hEpoR on
hematopoiesis needed to be further addressed in more prim-
itive hematopoietic stem cells.
Embryonic stem (ES) cells were derived from the inner
cell mass of 3.5-day blastocytes with totipotent differentia-
tion to committed-lineage hematopoietic cells and other
cells such as myocardial and endothelial cells [40-44]. In
vitro, spontaneous differentiation by withdrawal of leukemia
inhibitory factor (LIF) contributes to cystic embryoid bodies
(EBs) with endoderm, mesoderm, and ectoderm resembling
the 6- to 8-day egg cylinder stage in normal embryonic
development. Some EBs develop yolk sac–like blood islands
[41,44]. EpoR mRNA has been shown to be slightly
expressed in undifferentiated ES cells, and its expression can
be easily detected immediately after differentiation [44].
Therefore, the aim of this work was to evaluate the effects
of exogenously transduced EpoR on erythropoiesis in differ-
entiating ES cells by means of retrovirus-mediated gene
transfer of an hEpoR complementary DNA (cDNA). 
MATERIALS AND METHODS
Cells
The ES-D3 cell, a murine 129/Sv blastocyst-derived ES
cell line, and murine embryonic ﬁbroblast cells used as feeder
layers [45] were gifts from Dr. Jay A. Tischﬁeld, Rutgers Uni-
versity (Piscataway, NJ). Undifferentiated ES-D3 cells were
maintained in ES culture medium (Dubecco’s modiﬁed Eagle’s
medium [DMEM], high glucose; Gibco BRL, Grand Island,
NY) supplemented with 15% heat-inactivated fetal calf serum
(FCS) (Hyclone Laboratory, Logan, UT), 2 mmol/L gluta-
mine, 0.1 mmol/L β-mercaptoethanol (Sigma, St. Louis,
MO), 100 U/mL penicillin, 100 µg/mL streptomycin, 0.1
mmol/L nonessential amino acids (Gibco BRL) on gelatin-
coated culture dishes in the presence of 1000 U/mL recombi-
nant murine LIF (Gibco BRL). To prepare cells for gene
transfer, frozen ES cells were thawed and cultured on mito-
mycin C (Sigma)–treated embryonic ﬁbroblast feeder layers in
the presence of LIF. To prepare feeder layers, confluent,
healthy mouse embryonic ﬁbroblasts were split onto gelatin-
coated dishes containing ES medium and allowed to grow to
confluency. The medium was then replaced with fresh
DMEM with 10% FCS and 1 µg/mL mitomycin C. ES cells
were incubated at 37°C in 5% CO2 for 2 hours. The dishes
were washed with phosphate-buffered saline (PBS) 3 times
and resuspended in fresh ES medium. The mitomycin
C–treated cells were used within 5 days. After gene transfer
and selection in G418 (Gibco BRL) (0.75 mg/mL), polyclonal
ES cells were maintained in ES medium with LIF and incu-
bated at 37°C in 5% CO2. The cells were passaged every 2 to
3 days by trypsinization in 0.25% trypsin (Gibco BRL) in PBS
containing 1% FCS, washed, and resuspended in fresh ES
medium at 5 × 105 cells/mL.
Retrovirus-Mediated Gene Transduction 
The retroviral vector encoding hEpoR and the neomycin
phosphotransferase (Neo) gene pLhEpoRSN was constructed
from an EcoRI/XhoI fragment containing the hEpoR coding
sequence inserted into the cloning site of pLXSN, as previ-
ously described [28]. Before gene transduction, rapidly
growing and healthy single ES cells were replated into fresh
ES medium until the cells had grown to 80% confluency.
The medium was changed for fresh ES medium containing
half the amount of retroviral supernant with polybrene
(8 µg/mL) (Aldrich Chemical, Milwaukee, WI). G418 was
added 40 hours later at a concentration of 0.75 mg/mL to
aid in selecting G418-resistant cells. The stable hEpoR
cDNA–transduced cells, known as ES-hEpoR cells, that
contain the hEpoR coding sequence and the Neo gene
cDNA mock virus–transduced ES (ES-Neo) cells were
obtained after 2 weeks of selection in ES medium containing
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G418. Expression of Neo gene and hEpoR gene in these cell
pools was confirmed by reverse transcriptase–polymerase
chain reaction (RT-PCR) and Northern blot analysis.
In Vitro Differentiation of ES Cells
To initiate differentiation, ES cells were dissociated by
trypsinization, and differentiation was performed in suspen-
sion culture in 60-mm bacterial petri dishes in the same ES
medium mentioned above, in the absence of LIF and in the
presence of 1 U/mL recombinant human Epo. Single ES
cells were replated at 2 × 105 cells/mL in a ﬁnal volume of
5 mL medium to form EBs. EBs were maintained in a
humidified condition at 37°C and 5% CO2. Medium was
changed every 2 days by allowing EBs to settle down in a
tube, replacing the medium, and gently pipetting EBs into
fresh petri dishes. At various times of differentiation, the
EBs were harvested by centrifugation and used for colony
assay and extraction of total RNA.
Colony Assay
For colony assay, EB-derived cells were harvested by dis-
sociating them in 0.25% collagenase medium at 37°C for
1 hour and passing the cells slowly through a 23-gauge
syringe needle. Cells were washed in PBS containing
1% FCS, and live cells were counted by trypan blue exclu-
sion. Single undifferentiated ES cells and EB-derived cells,
harvested at days 6, 10, and 14 of differentiation, were
cultured at a concentration of 104 cells/mL in 1% methyl-
cellulose, 30% FCS, 2 mmol/L glutamine, 0.1 mmol/L
β-mercaptoethanol, and 0.1 mmol/L hemin (Eastman
Kodak, Rochester, NY) in 35-mm diameter culture dishes
for colony formation as previously described [28,39].
Recombinant murine preparations of granulocyte-
macrophage colony-stimulating factor (GM-CSF), IL-3, and
Steel factor (SLF) were purchased from R&D Systems (Min-
neapolis, MN), and used at concentrations of 200 U/mL,
200 U/mL, and 50 ng/mL, respectively. Recombinant human
Epo was purchased from Amgen (Thousand Oaks, CA) and
used at a concentration of 1 U/mL. Cells were cultured at
37°C, 5% CO2, and 5% O2. Colony-forming unit–granulocyte
macrophage (CFU-GM), multipotential CFU (CFU-Mix),
and deﬁnitive erythroid colonies (Ery-D) were scored after
8 days of culture, and primitive erythroid colonies (Ery-P) were
scored after 4 days of culture [44,46]. Individual Ery-P and
Ery-D colonies were distinguished by the size of the cells
within the colonies and by the fact that Ery-P colonies were a
more brilliant red color than Ery-D colonies. Cells in Ery-P
colonies are large and nucleated, whereas cells in Ery-D
colonies are smaller and enucleated [47].
To evaluate the formation of blood island–containing
EBs, ES cells were plated in 1% methylcellulose culture
medium as mentioned above, in either the presence or the
absence of growth factors. Cells were allowed to differenti-
ate for 7 to 14 days; EBs were counted; and those EBs con-
taining hemoglobinized cells were scored as erythroid cell
positive [44]. Significant differences between groups were
determined by the Student t test.
RT-PCR Analysis
Total RNA was isolated from undifferentiated ES, ES-
Neo, ES-hEpoR cells (day 0), and from EB-derived cells at
days 2, 4, 6, 8, 10, and 14 of differentiation by Qiagen
RNeasy Mini Kits (Qiagen, Hilden, Germany) as suggested
by the manufacturer. Total RNA was treated with recombi-
nant human deoxyribonuclease I (DNase I) for 15 minutes at
room temperature and was inactivated by heating at 95°C for
10 minutes before the addition of reverse transcriptase (RT)
to eliminate any contamination of remaining genomic DNA.
One microgram of total RNA lysate in 20 µL RT buffer (RT
buffer: 25 mmol/L Tris-HCl [pH 8.3], 37.5 mmol/L KCl,
1.5 mmol/L MgCl2, 5 mmol/L dithiothreitol, 10 mmol/L
deoxyribonucleoside triphosphate mixture, 0.5 mg/L Oligo
[dT]15 primer], 26 units RNasin, and 200 units murine
Moloney leukemia virus reverse transcriptase [Promega,
Madison, WI]) was used for RT. After cDNA synthesis, 1 µL
of the cDNA solution synthesized from 50 ng total RNA was
used for PCR ampliﬁcation. This was performed in 50 µL of
reaction mixture containing 1 × PCR buffer, 60 µmol/L of
dNTP, 2 units Taq polymerase (Boehringer Mannheim,
Mannheim, Germany), and 0.5 µmol/L of each specific
primer. PCR was performed by a thermal cycler (Perkin
Elmer Cetus, Norwalk, CT). For Neo gene expression, the
sequence of primers were 5′ CAA GAT GGA TTG CAC
GCA GGT TCT CCG 3′ as sense strand and 5′ CCA GAG
TCC CGC TCA GAA GAA CTC GTC 3′ as antisense
strand. The PCR condition was denaturation at 94°C for 45
seconds, annealing at 60°C for 45 seconds, and polymeriza-
tion at 72°C for 2 minutes for 35 cycles. For expression of
transduced hEpoR gene, the sequence of primers was as fol-
lows: 5′ CCC CTA CCC ACC CCA CCT AA 3′ of hEpoR
cDNA as sense strand and 5′ ACC TGC GTG CAA TCC
ATC TTG 3′ corresponding to the Neo gene of the pLXSN
as antisense strand as previously described [28,39]. The PCR
condition was denaturation at 95°C for 25 seconds, anneal-
ing at 65°C for 30 seconds, and polymerization at 72°C for
2 minutes for 35 cycles. The primers and annealing tempera-
ture of ampliﬁcation for globin genes and transcription fac-
tor genes are shown in the Table [41,49]. Ten microliters
amplified product were electrophoresed, transferred to
membrane, and hybridized with a [32P]dCTP (Amersham,
Arlington Heights, IL)-labeled XhoI-EcoRI digested pLXSN
Neo gene fragment and a HindIII-EcoRI digested hEpoR
gene fragment from the pLhEpoRSN plasmid as a probe.
Hybridization was performed overnight at 42°C, and ﬁlters
were washed with 0.1× SSC in 0.1% SDS at 55°C for 60
minutes, dried, and exposed to x-rays at –70°C.
Northern Blot Analysis 
A total of 15 µg of RNA extracted from parental ES,
ES-Neo, or ES-hEpoR cells was electrophoresed on 1%
agarose-formaldehyde gel, blotted to Genescreen Plus nylon
membrance, and hybridized with [32P]dCTP-labeled hEpoR
gene fragment as a probe. For expression of murine EpoR,
β-H1, β-Major and GATA-1 genes, the probes were generated
by RT-PCR ampliﬁcation. PCR products were cloned into
pGEM-T vector (Promega). The inserted fragments were
confirmed by direct sequencing. Probe labeling was per-
formed by using an oligolabeling kit (Pharmacia Biotech, Pis-
cataway, NJ). Prehybridization was performed at 68°C in
Hyperexpress hybridization solution (Clontech, Palo Alto,
CA) with 100 µg/mL denatured salmon-testes DNA (Sigma)
for 1 hour, and hybridization was performed under the same
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conditions as prehybridization for 1 hour without salmon-
testes DNA. After hybridization, the ﬁlter was washed with 2×
SSC in 0.05% SDS and 0.1× SSC in 0.1% SDS at room tem-
perature for 60 minutes, dried, and exposed to x-rays at –70°C
overnight. Visualized bands were quantitated using Sigma Gel
Software and Scanner (Jandel Scientiﬁc, San Rafael, CA).
RESULTS
Expression of Human EpoR and Endogenous Murine
EpoR Gene in ES-hEpoR Cells
Parental ES cells were transduced with retroviral
pLhEpoRSN or mock control pLXSN and selected with
G418. After 2 weeks of selection, the cells integrating and
expressing transduced Neo, a selectable marker gene, sur-
vived, expanded, and were designated as ES-hEpoR (for those
cells integrating transduced Neo) and ES-Neo (for those
cells expressing transduced Neo). G418 was added every
2 weeks for all the experiments, and each individual experi-
ment was performed using freshly thawed frozen cells. The
predicted products of the transduced hEpoR gene in ES-EpoR
cells and the Neo gene in both the ES-hEpoR and ES-Neo
cells were detected by RT-PCR analysis (Figure 1A). North-
ern blot analysis was applied to further conﬁrm expression of
the transduced hEpoR gene, and a speciﬁc 1.6-kilobase (kb)
band transcripted from pLhEpoRSN was detected using
hybridization with 32P-labeled hEpoR gene fragment in ES-
EpoR cells, but not in parental ES or ES-Neo cells (Figure
1B). Expression of the transduced hEpoR gene was constantly
detected by Northern blot analysis in ES-hEpoR cells, but
not ES-Neo cells, undergoing differentiation, although a
slight decrease was observed during differentiation (Figure
2). In contrast, the expression of murine EpoR was detected
at a very low level in undifferentiated ES-Neo cells and was
greatly enhanced at day 4 to 14 of differentiation. Transduc-
tion of hEpoR did not change the expression pattern of
endogenous murine EpoR (Figure 2). No difference was
detected for the expression of murine EpoR between ES-Neo
and parental ES cells (data not shown). The expression pat-
tern of murine EpoR in parental ES cells is consistent with
that in other reports [41,44,48]. 
Increases in Formation of Blood Islands in EBs, but Not
in Plating Efficiencies of EBs, From ES-hEpoR Cells
In vitro differentiation of ES cells by withdrawal of LIF
can generate EBs in either suspension culture or methylcel-
Oligonucleotide Primers Used for Gene Expression Analysis by reverse transcriptase–polymerase chain reaction (RT-PCR) [41,49]
Gene Size (bp)* T(C°)† 5 Primer 3 Primer
GATA-1 581 55 5-ATGCCTGTAATCCCAGCACT-3 5-TCATGGTGGTAGCTGGTAGC-3
c-myb 681 55 5-TTCAAGGCCAGCATTCTTGC-3 5-CCTCTAGGAGCTCATTTGTG-3
scl 396 55 5-TATGAGATGGAGATTTCTGAT G-3 5-GCTCCTCTGTGTAACTGTC-3
NF-E2 391 62 5-GAGCCCTGGCCATGAAGATTCC-3 5-CACCATCAGCAGCCTGTTGCAG-3
EKLF 359 55 5-TCGCCGGAGACGCAGGCT-3 5-CCCAGTCCTTGTGCAGGA-3
EpoR 452 55 5-GGACACCTACTTGGTATTGG-3 5-GACGTTGTAGGCTGGAGTCC-3
-H1 256 55 5-ATGCCCCATGGAGTCAAAGA-3 5CTCAAGGAGACCTTTGCTCA-3
-Major 578 55 5-CTGACAGATGCTCTCTTGGG-3 5-CACAACCCCAGAAACAGACA-3
*Predicted size of RT-PCR products.
†Annealing temperature.
Figure 1. Detection of the expression of the transduced hEpoR gene
and the Neo gene in undifferentiated embryonic stem (ES) cells.
A. Reverse transcriptase–polymerase chain reaction (RT-PCR) analysis.
The ampliﬁed products were subjected to Southern blotting using 32P-
labeled hEpoR and Neo gene fragments as probes. B. Northern blot
analysis. Fifteen micrograms of total RNA was electrophoresed on a
1% agarose gel, transferred to Genescreen Plus nylon membrane, and
hybridized with a 32P-labeled hEpoR cDNA fragment. -actin was used
as messenger RNA control. 1 indicates parental ES cells; 2, ES-Neo
cells; 3, ES-hEpoR cells.
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lulose culture [44,49]. When ES cells were seeded at a con-
centration of 104 cells in 1 mL methylcellulose culture
medium without hematopoietic growth factors, a total of
300 to 350 EBs were generated by day 7 of differentiation.
The addition of GM-CSF, IL-3, and SLF with or without
Epo did not significantly influence plating efficiencies.
Expression of the hEpoR gene in ES cells neither changed
the plating efficiencies nor modified the independence of
EBs to growth factors (Figure 3A). 
Some EBs contained visible blood islands after 7 to
10 days of cultures. This early stage of erythropoiesis
appeared as a relatively small red area within the center of
the EBs; hemoglobinization increased swiftly during the
ensuing days of differentiation, with bright red color occur-
ring at about day 14 of differentiation (Figure 4A). Some
EBs ruptured, releasing red erythroid colonies that remained
at the periphery of the EBs (Figure 4B). 
In this study, we observed that 33.7% and 31.2% of EBs
from parental ES and ES-Neo cells, respectively, contained
visible blood islands at day 14 of differentiation after culture
in the presence of GM-CSF, IL-3, SLF, and Epo (Figure
3B). Expression of the hEpoR gene in ES cells contributed to
the significantly enhanced formation of blood island–con-
taining EBs (53.8%) at day 14 of differentiation (see Fig-
Figure 2. Detection by Northern blot analysis of expression of the transduced hEpoR gene and the endogenous murine EpoR gene in ES-Neo and ES-
hEpoR cells during differentiation. Results from 1 of 3 representative experiments are shown. Fifteen micrograms of total RNA extracted from undiffer-
entiated embryonic stem (ES) cells (day 0) and embryoid bodies (EBs) harvested at days 4, 6, 8, 10, and 14 of differentiation in the presence of 1 U/mL
Epo were subjected to electrophoresis on 1% agarose-formaldehyde gel, blotting to Genescreen Plus nylon membrane, and hybridization with
[32P]dCTP-labeled hEpoR (1.8 kb) or murine EpoR (0.5 kb) gene fragment as a probe. The expression of -actin gene was used as messenger RNA
(mRNA) control. Note that because different-length probes were used to detect mRNA expression of the human and murine EpoR, and blot signals are
related to hybridization efﬁciencies, which may vary between these probes, it is difﬁcult to directly compare the relative expression of the human EpoR
to that of the murine EpoR. 
Figure 3. Development of embryoid bodies (EBs) and blood islands within EBs during differentiation of parental embryonic stem (ES), ES-Neo, and
ES-hEpoR cells. A. The total number of EBs generated from 104 cells in 1 mL methylcellulose culture medium with or without hematopoietic growth
factors, as indicated, at day 7 of differentiation. B. The percentage of blood island–containing EBs on day 14 of differentiation in the absence and pres-
ence of Steel factor (SLF), interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF), and erythropoietin (Epo). Results from
3 separate experiments are expressed as mean ± SD. a indicates signiﬁcant (P < .05) differences from parental ES and ES-Neo cells.
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Figure 4. Representative blood island–containing embryoid bodies (EBs) on day 14 of differentiation of embryonic stem (ES) cells. A. The blood island
within the center of the EB from ES-Neo cells is indicated by the arrow. B. Ruptured EB derived from an ES-hEpoR cell releasing large erythroid burst
colonies in the periphery of the EB. (Original magniﬁcation, 40)
Figure 5. Time course of development of hematopoietic colonies from ES-Neo and ES-hEpoR cells. Cells were plated at 104/mL in methylcellulose
culture in the absence (A-D) or presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and Steel factor
(SLF) with (E-H) and without (I-L) Epo. Results from 5 separate experiments are expressed as mean ± SD. a indicates signiﬁcant (P < .05) differ-
ences from parental ES-Neo cells. Ery-D indicates deﬁnitive erythroid colony; Ery-P, primitive erythroid colony; CFU-Mix, multipotential colony-
forming unit; CFU-GM, colony-forming unit–granulocyte/macrophage.
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ures 3B and 4B) when compared with parental ES and
ES-Neo cells grown in the presence of these same cytokines.
This enhancement of formation of blood island–containing
EBs was also observed from ES-hEpoR cells in the absence
of cytokines (Figure 3B).
Increased Erythroid Progenitors in ES-hEpoR Cells
To investigate the possible effects of the human EpoR
gene on the proliferation and differentiation of erythroid
precursors in EBs, EB-derived cells, at different times of
differentiation in suspension culture, were replated in
methylcellulose cultures for colony formation. Differenti-
ating ES cells generated CFU-Mix, Ery-P, Ery-D, and
GM-CFU. Results from 5 experiments showed that in the
absence of cytokines, transduction of hEpoR gene in ES
cells, slightly but significantly increased colony numbers
from Ery-D and Ery-P (Figure 5A and 5B). In the pres-
ence of GM-CSF, IL-3, SLF, and Epo, Ery-D colonies
were further enhanced by 3.3-, 4.2-, and 2.0-fold at days 6,
10, and 14 of differentiation from ES-hEpoR cells, respec-
tively, when compared with differentiation from ES-Neo
cells (Figure 5E). Similar results were detected in Ery-P
colonies from ES cells. In the presence of the same growth
factors, a 3.3- and 2.7-fold increase in Ery-P occurred at
days 6 and 10 of differentiation from ES-hEpoR cells,
respectively, when compared with differentiation from ES-
Neo cells (Figure 5F). GM-CSF, IL-3 and SLF, in the
absence of Epo, did not enhance formation of Ery-D (Fig-
ure 5I) or Ery-P (Figure 5J) colonies from ES-hEpoR cells
beyond that of cells cultured in medium control without
growth factors. Furthermore, no differences in formation
of colonies were noted between parental ES and ES-Neo
cells (data not shown). The erythroid colonies formed
from ES-hEopR cells were larger and more hemoglo-
binized than those from ES-Neo cells (Figure 6). These
results suggest that the human EpoR gene contributed to
the enhanced growth of both primitive and definitive ery-
throid progenitors in EBs.
Transduction of the hEpoR gene also contributed to
signiﬁcant increases in CFU-Mix colonies from days 6 to 14
of differentiation in the absence of cytokines. This increase
for CFU-mix was slightly but signiﬁcantly enhanced on day
14 of differentiation by the addition of Epo to GM-CSF,
IL-3, and SLF, but not in the absence of Epo (Figure 5C,
5G, and 5K), suggesting that the hEpoR gene might con-
tribute to augmentation of multipotential precursors in the
differentiation of ES cells. In contrast, no differences could
be detected for CFU-GM colonies in ES-hEpoR cells and
ES-Neo cells during differentiation with or without growth
factors (Figure 5D, 5H, and 5L).
Expression of Globin Genes in Differentiating EBs
To further evaluate the differentiation of erythroid pre-
cursors to mature red cells in ES-EpoR cells, the expression of
fetal and adult globin genes were examined by Northern blot
analysis. The expression of the β-H1 globin gene was first
detected at a very low level on day 6 in ES-Neo cells in the
presence of Epo. The expression was greatly increased by day
8 of differentiation, with maximal expression occurring on
day 10 of differentiation. Elevated expression of the β-H1 glo-
bin gene was noted in ES-hEpoR cells, when compared with
ES-Neo cells, beginning on day 8 of differentiation (Figure
7A). Relative expression of the β-H1 globin gene, compared
with control expression of the β-actin gene, showed 3- to
5-fold enhancement during days 8 to 14 of differentiation in
ES-hEpoR cells when compared with similar expression in
mock virus–transduced ES cells (Figure 7B). Elevated expres-
sion of β-Major globin gene was also detected at days 8, 10,
Figure 6. Representative deﬁnitive erythroid colonies (Ery-D) from ES-Neo cells (A) and ES-hEpoR cells (B), and primitive erythroid colonies
(Ery-P) from ES-Neo cells (C) and ES-hEpoR cells (D). (Original magniﬁcation, 80)
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and especially 14 of differentiation in ES-hEpoR cells when
compared with ES-Neo cells (Figure 8). 
Expression of Transcription Factor Genes in EBs
To address possible transcriptional regulation of these
globin genes, expression of several transcriptional factor
genes—GATA-1, EKLF, NF-E2, c-myb, and scl, which are
believed to play important roles in erythropoiesis—was ana-
lyzed by RT-PCR (data not shown); results for GATA-1
were conﬁrmed by Northern blot analysis (Figure 9A). The
GATA-1 gene was detected at a low level of transcription in
ES-Neo cells on days 0 to 4 of differentiation; expression
was increased after 6 days of differentiation to a maximal
level on days 10 to 14 of differentiation. Expression of the
GATA-1 gene in hEpoR-transduced ES cells was enhanced
1.5 to 3 times when compared with similar expression in
ES-Neo cells during days 0 to 8 of differentiation (Figure
9B). This increased expression of the GATA-1 gene might
contribute to earlier and increased expression of globin
genes and to the switch of globin genes from fetal to adult.
In contrast, no differences in the expression level and pat-
tern of other transcription factor genes (eg, EKLF, NF-E2,
c-myb, and scl) were noted between ES-hEpoR and ES-Neo
cells during the entire time course of differentiation as
assessed by RT-PCR analysis (data not shown).
DISCUSSION
Hematopoietic growth factor receptors play important
roles in normal hematopoiesis by binding their cognate
ligands and transducing intracellular signals responsible for
cell proliferation and terminal differentiation. Lineage-
specific cytokine receptors, such as EpoR, G-CSFR,
M-CSFR and c-mpl, are intimately involved in the output of
mature cells from lineage-specific committed progenitors,
and these receptors are expressed during the commitment of
stem cells to their progenitors. However, the role of lineage-
speciﬁc cytokine receptors in proliferation and differentia-
Figure 7. A. Detection by Northern blot analysis of expression of -H1 globin genes in ES-Neo and ES-hEpoR cells during differentiation; results from
1 of 4 representative experiments are shown. Fifteen micrograms of total RNA extracted from undifferentiated embryonic stem (ES) cells (day 0) and
embryoid bodies (EBs) harvested at days 2, 4, 6, 8, 10, and 14 of differentiation after culture in the presence of 1 U/mL erythropoietin (Epo) were sub-
jected to electrophoresis on 1% agarose-formaldehyde gel, blotting to Genescreen Plus nylon membrane, and hybridization with [32P]dCTP-labeled
-H1 globin gene fragment as a probe. B. Relative expression was calculated by comparison with expression of the -actin gene. Results from 4 separate
experiments are expressed as mean + SD.
A
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tion of embryonic stem cells remains unclear. The establish-
ment of ES cell lines has provided a model system with
which to study early hematopoietic development. This sys-
tem has been used widely to correlate expression of
cytokines, their receptors, globins, and a series of hemato-
poietic cell surface markers throughout hematopoietic
development in vitro [40-43,49].
In the present study, signiﬁcantly increased numbers of
erythroid progenitors were noted within EBs generated from
hEpoR cDNA–transduced and stably expressed ES cells when
compared with EBs from mock virus–transduced ES-Neo
cells. Increased numbers of erythroid colonies, including
Ery-D and Ery-P, were derived from EBs of ES-hEpoR cells.
Production of CFU-mix colonies, but not CFU-GM
colonies, from ES-hEpoR cells was also slightly increased.
These results, together with the enhanced formation of
blood islands within developing EBs after the introduction of
hEpoR cDNA into ES cells, demonstrate that introduction of
the hEpoR gene contributes to production of fetal and adult
erythroid progenitor cells in developing EBs, and that the
enhancement might not be entirely owing to the effects of
exogenously added Epo. Several possibilities exist to explain
the exogenous Epo-independent erythropoiesis in the devel-
opment of blood islands and erythroid colonies in EpoR
cDNA–transduced ES cells in the absence of Epo. First,
totipotential ES cells are able to differentiate into all tissue
cells, including those cells producing endogenous Epo,
which in turn could trigger EpoR signals in developing EBs
[40,41]. Second, transduced EpoR might result in a relatively
higher level of expression of EpoR under the control of a
strong promoter and could induce spontaneous activation or
formation of ligand-independent EpoR dimerization that
might be sufﬁcient to elicit a differentiation signal. Third, it
is conceivable that the function of the EpoR may be modu-
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Figure 8. A. Detection by Northern blot analysis of expression of the -Major globin gene in ES-Neo and ES-hEpoR cells during differentiation;
results from 1 of 3 representative experiments are shown. Fifteen micrograms of total RNA extracted from undifferentiated embryonic stem (ES)
cells (day 0) and embryoid bodies (EBs) harvested at days 2, 4, 6, 8, 10, and 14 of differentiation after culture in the presence of 1 U/mL erythropoi-
etin (Epo) were subjected to electrophoresis on 1% agarose-formaldehyde gel, blotting to Genescreen Plus nylon membrance, and hybridization
with [32P]dCTP-labeled -Major globin gene fragment as a probe. B. Relative expression was calculated by comparison with expression of the
-actin gene. Results from 3 separate experiments are expressed as mean + SD.
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lated by other growth factors present in the culture environ-
ment or in developing EBs, such as SLF, that can phospho-
rylate the EpoR [50]. Also, the EpoR may be activated by trace
amounts of bovine factors present in the medium. It has been
reported that the lower the concentration of Epo in the cul-
ture, the higher the degree of differentiation in EpoR-trans-
duced Ba/F3 cells [51]. 
Enhanced output of erythroid cells was suggested by
globin gene expression studies. Although the expression pat-
tern was not significantly changed by introduction of the
hEpoR gene into ES cells, the relative expression level was
elevated in ES-hEpoR cells when compared with ES-Neo
cells. In both ES-Neo and ES-hEpoR cells, expression of
fetal globin genes, such as β-H1 globin, was elevated on days
8 to 14 of differentiation but decreased on day 14 of differ-
entiation. Elevated expression of adult β-Major globin gene
was observed on days 8 to 14 of differentiation, but was
most apparent at later stages (days 10 and 14) when com-
pared with ES-Neo cells. These results are consistent with
globin gene switching from embryonic to fetal/adult globin
genes [52] and indicate that both primitive and definitive
erythroid progenitors could be enhanced by transduction of
the hEpoR gene into ES cells. Globin gene switching from
fetal to adult type was enhanced in ES-hEpoR cells as well. 
Of particular interest, one of the transcription factor
genes, GATA-1, displayed enhanced expression during dif-
ferentiation of ES-hEpoR cells when compared with mock
virus–transduced ES cells. GATA-1 plays a crucial role in
eythropoiesis because it binds to a motif (A/T)GATA(A/G)
that is found in the promoters and enhancers of nearly all
erythroid cell–speciﬁc genes studied thus far, including the
globin genes and their respective locus control regions [53-
56]. Targeted disruption of the GATA-1 gene in mice leads
to failure in production of mature red blood cells and apo-
ptosis of committed erythroid precusors [57]. Introduction
of a normal GATA-1 gene into GATA-1– mouse ES cells
Figure 9. A. Detection by Northern blot analysis of expression of the GATA-1 gene in ES-Neo and ES-hEpoR cells during differentiation; results
from 1 of 4 representative experiments are shown. Fifteen micrograms of total RNA extracted from undifferentiated embryonic stem (ES) cells (day 0)
and embryoid bodies (EBs) harvested at days 2, 4, 6, 8, 10, and 14 of differentiation after culture in the presence of 1 U/mL erythropoietin (Epo) were
subjected to electrophoresis on 1% agarose-formaldehyde gel, blotting to Genescreen Plus nylon membrane, and hybridization with [32P]dCTP-labeled
GATA-1 gene fragment as a probe. B. Relative expression was calculated by comparison with expression of the -actin gene. Results from 4 separate
experiments are expressed as mean + SD.
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restores the developmental potential of primitive and deﬁni-
tive erythroid cells [58]. GATA-1 and Epo cooperate to pro-
mote survival of erythroid cells [59]. GATA-1 also appears
to be central to the regulation of transcription of the EpoR
gene [53]. It has been noted that the activation of GATA-1
could be enhanced by Epo–EpoR signaling in several cell
lines, such as Ba/F3 and J2E [54,60]. In our study, GATA-1
is expressed at a low level in undifferentiated mock
virus–transduced ES cells but is increased after 6 days of dif-
ferentiation. In contrast, elevated expression of this gene
was seen at days 0 through 8 of differentiation in ES-EpoR
cells as compared with ES-Neo cells. It has been reported
that Epo–EpoR signaling transactivates GATA-1 gene
expression after stimulation of cells with Epo. This concurs
with the observation that progressive GATA-1 gene expres-
sion appears only in later erythroid differentiation stages. A
low level of GATA-1 expression occurring by itself before
Epo stimulation is not enough to transactivate erythroid-
specific gene expression, although activation of the EpoR
gene by the GATA-1 gene may be possible at this differenti-
ation stage [54]. Activation of the EpoR gene, combined with
expression of GATA-1, might be able to transactivate ery-
throid-speciﬁc genes at this differentiated stage [61]. There-
fore, we believe that enhancement of globin gene expression
by transduction of the hEpoR gene in ES cells might be
mediated, at least partly, by the transactivation of GATA-1,
which in turn activates globin gene expression at later differ-
entiation stages in these cells. We failed to detect differences
in the expression levels and patterns of other transcription
factors, such as NF-E2, c-myb, scl, and EKLF, in ES-hEpoR
cells when compared with parental ES or ES-Neo cells, sug-
gesting that these genes might not play an essential role in
the observations we have made. 
It is conceivable that the enhanced erythropiesis in devel-
oping EBs derived from hEpoR-transduced ES cells might be
a result of signals tranduced by hEpoR to support proliferation
and differentiation of erythroid progenitors derived from
these cells. However, we cannot exclude the possible role of
hEpoR in transducing speciﬁc signals for differentiation of ES
cells to erythroid lineage. Although evidence indicates that
the Epo–EpoR signal is not speciﬁcally required for erythroid
differentiation [39], our data partially support the role of
transduced hEpoR in the production of erythroid precursors
in differentiating ES cells. Some studies have indicated that
the cytoplasmic region of EpoR contains a differentiation
domain that is unique to the EpoR and different from the
cytoplasmic region of other hematopoietic growth factor
receptors [36]. Human EpoR transgenic mice have been estab-
lished using a genomic fragment containing the hEpoR gene,
and they exhibit correct developmental hematopoietic and
neural expression [62,63]. By using an ES cell model in our
study, expression of the hEpoR gene was constantly detected
during in vitro differentiation. Future studies creating hEpoR
transgenic mice using this ES cell model may further address
the role of EpoR in primitive hematopoietic stem cells. 
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